---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-277541"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2023-11-15T23:59:59+00:00"
generated_at: "2026-06-08T01:58:05.360176+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alaunos terminates SVP Legal and VP R&D; execs receive separation payments, consulting

## Summary
- Melinda Lackey (SVP, Legal) and Drew Deniger (VP, R&D) terminated without cause, effective Nov 15, 2023.
- Lackey receives $180,000 separation payment; Deniger receives $182,500 separation payment.
- Lackey enters consulting agreement at $400/hour to assist with strategic alternatives review.
- Deniger agrees to cooperate on investigations and strategic alternatives for scientific assets.

## SEC filing metadata
- accession: 0001193125-23-277541
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2023-11-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119312523277541/0001193125-23-277541-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119312523277541/d850558d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-277541
- JSON: https://secwatch.observer/filing/0001193125-23-277541.json
- Plain text: https://secwatch.observer/filing/0001193125-23-277541.txt

## Key facts
- Executive change
  Melinda Lackey was terminated as Senior Vice President, Legal and Administration at Alaunos Therapeutics, Inc..
  - Action: terminated
  - Role: Senior Vice President, Legal and Administration
  source text: the Company terminated the employment of Melinda Lackey, Senior Vice President, Legal and Administration
  evidence_url: https://www.sec.gov/Archives/edgar/data/1107421/000119312523277541/0001193125-23-277541-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.